Commentary: Are we there yet? Role of anti-vascular endothelial growth factor and laser in the management of retinopathy of prematurity

Commentary: Are we there yet? Role of anti-vascular endothelial growth factor and laser in the management of retinopathy of prematurity

Bibliographic Details
Main Authors:	Manavi D Sindal, Divya Yadav
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Indian Journal of Ophthalmology
Online Access:	http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=8;spage=2176;epage=2177;aulast=Sindal

Similar Items

Commentary: Parental involvement in retinopathy of prematurity care: An individualized approach
by: Manavi D Sindal, et al.
Published: (2021-01-01)

Commentary: Looking beyond anti-vascular endothelial growth factor – Novel therapeutic targets for retinopathy of prematurity
by: Mohit Dogra, et al.
Published: (2021-01-01)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
by: Ajay Indur Dudani, et al.
Published: (2019-01-01)

Retinopathy of prematurity: Screening challenges
by: Kannegolla Anudeep, et al.
Published: (2020-01-01)

Vascular endothelial growth factor inhibitors for retinopathy of prematurity
by: O.V. Zhukova, et al.
Published: (2020-11-01)

Anti-vascular endothelial growth factor in the management of retinopathy of prematurity: A survey among the members of Indian Retinopathy of Prematurity Society
by: Anil Gangwe, et al.
Published: (2021-01-01)

Refractive errors in premature infants with retinopathy of prematurity after anti-vascular endothelial growth factor (anti-VEGF) therapy
by: Vujanović Milena S., et al.
Published: (2017-01-01)

Commentary: Retinopathy of prematurity: Where do we stand?
by: Swapnil M Parchand, et al.
Published: (2021-01-01)

Profile of patients receiving intravitreal anti-vascular endothelial growth factor injections during COVID-19-related lockdown
by: Manavi D Sindal, et al.
Published: (2021-01-01)

Commentary: Functional outcome after successful laser for retinopathy of prematurity – Where we stand?
by: Ekta Rishi, et al.
Published: (2019-01-01)

Timing of laser following intravitreal anti-vascular endothelial growth factor injections for aggressive posterior zone 1 retinopathy of prematurity
by: Anand Vinekar
Published: (2021-01-01)

Comparison of efficacy between anti-vascular endothelial growth factor (VEGF) and laser treatment in Type-1 and threshold retinopathy of prematurity (ROP)
by: Zijing Li, et al.
Published: (2018-01-01)

Intraocular and systemic levels of vascular endothelial growth factor in advanced cases of retinopathy of prematurity
by: Raul Velez-Montoya, et al.
Published: (2010-08-01)

Study of incidence, risk factors, and treatment outcomes in retinopathy of prematurity in a tertiary care center
by: Kannegolla Anudeep, et al.
Published: (2019-01-01)

Commentary: Optimizing surgical training
by: Manavi D Sindal, et al.
Published: (2020-01-01)

Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity
by: Min Zhao, et al.
Published: (2015-01-01)

Commentary: Continuation of care - Refraction beyond regression
by: Manavi D Sindal, et al.
Published: (2019-01-01)

Serum Erythropoietin, Insulin-Like Growth Factor 1 and Vascular Endothelial Growth Factor in Ethiopathogenesis of Retinopathy of Prematurity
by: Özlem Yenice, et al.
Published: (2012-12-01)

Serum Vascular Endothelial Growth Factor Levels before and after Intravitreous Ranibizumab Injection for Retinopathy of Prematurity
by: Xuting Chen, et al.
Published: (2019-01-01)

Diabetic retinopathy and vascular endothelial growth factor
by: Majid Khazaei
Published: (2013-01-01)

Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review.
by: Qing-Qing Tan, et al.
Published: (2019-01-01)

The role of anti-vascular endothelial growth factor (anti-VEGF) in the management of proliferative diabetic retinopathy
by: Yue Zhao, et al.
Published: (2018-08-01)

Commentary: Sealing breaks comfortably— A novel approach to retinopexy without positioning
by: Manavi D Sindal, et al.
Published: (2019-01-01)

Timing of Retinopathy of Prematurity Laser
by: Po-Chen Tseng, et al.
Published: (2014)

Are anti-vascular endothelial growth factor drugs the panacea for all diabetic retinopathy patients?
by: Jacob Koshy
Published: (2013-01-01)

A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity.
by: Laura Pertl, et al.
Published: (2015-01-01)

Intravitreal antivascular endothelial growth factors for retinopathy of prematurity in Ibadan: Method of administration
by: Yewande Olubunmi Babalola, et al.
Published: (2020-01-01)

Study of anti-vascular endothelial growth factor medicine for proliferative diabetic retinopathy at perioperative period
by: Mei Sun, et al.
Published: (2015-10-01)

Commentary: Fibrin glue in rhegmatogenous retinal detachment repair—Are we there yet?
by: Kumar Anshuman, et al.
Published: (2019-01-01)

Commentary: Prognostication of uveal melanoma based on molecular diagnosis - Are we there yet?
by: Yamini Attiku, et al.
Published: (2019-01-01)

Anti-VEGF therapy in retinopathy of prematurity
by: Qin Peng, et al.
Published: (2020-11-01)

Commentary: Switching of anti-vascular endothelial growth factor agents in refractory diabetic macular edema
by: Dhanashree Ratra
Published: (2021-01-01)

Commentary: "Indovation" in retinopathy of prematurity management during COVID-19 times
by: Simar Rajan Singh, et al.
Published: (2021-01-01)

Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature
by: Irini Chatziralli, et al.
Published: (2021-07-01)

The Role of Focal Laser in the Anti–Vascular Endothelial Growth Factor Era
by: Jason N Crosson, et al.
Published: (2017-11-01)

Diode Laser Photocoagulation in the Treatment of Retinopathy of Prematurity
by: Murat Günay, et al.
Published: (2013-10-01)

Bevacizumab or laser for aggressive posterior retinopathy of prematurity
by: Michael Blair, et al.
Published: (2018-01-01)

Anti-VEGF therapy in the management of retinopathy of prematurity: what we learn from representative animal models of oxygen-induced retinopathy
by: Wang H
Published: (2016-05-01)

Correlation of vascular endothelial growth factor and microvascular damage in diabetic retinopathy
by: Ji-Quan Wen, et al.
Published: (2015-12-01)

Commentary: Anti-vascular endothelial growth factor therapies in vitreo-retina practice: Biosimilars versus biologics
by: Giridhar Anantharaman
Published: (2021-01-01)